This two-part series reviews innovative sustained-delivery options for both long- and short-term indications.
Here, in part 2, I cover corticosteroid formulations and implants designed for postoperative use. In part 1, I reviewed longer-acting implants for chronic conditions.
Postoperative inflammation is a natural consequence of vitreoretinal surgery and is often controlled with topical corticosteroids. Patients prescribed corticosteroid drops after ocular surgery often have difficulty adhering to the regimen. They do not get the prescription filled, forget to administer the drops as